Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (bilateral)
ICD-10 E09.3553 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (bilateral).
E09.3553 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of stable proliferative diabetic retinopathy in both eyes. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. Proliferative diabetic retinopathy is a severe complication of diabetes, where abnormal blood vessels grow on the retina, potentially leading to vision loss. The term 'stable' indicates that the retinopathy has not progressed, which is crucial for management and treatment planning. Patients may require regular monitoring of HbA1c levels to assess long-term glucose control, with targets typically set below 7% for most adults. Insulin management may be necessary, especially if oral hypoglycemics are ineffective due to the drug-induced nature of the diabetes. This code emphasizes the importance of identifying the underlying cause of diabetes and managing its complications effectively.
Detailed medication history, HbA1c levels, and retinopathy assessments.
Patients with drug-induced diabetes requiring insulin therapy and monitoring for retinopathy.
Endocrinologists must ensure accurate documentation of the drug causing diabetes and its management.
Visual acuity tests, retinal examinations, and documentation of retinopathy status.
Patients presenting with vision changes due to diabetic retinopathy.
Ophthalmologists should document the stability of retinopathy and any interventions performed.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and retinopathy assessment.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Medications such as corticosteroids, certain antipsychotics, and some immunosuppressants can induce diabetes by affecting insulin sensitivity or secretion.
